Consolidated Condensed Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Cash flows from operating activities:
Net income including noncontrolling interests	$ 22,296	$ 3,674
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,178	12,430
Impairment charges and other		279
Income from equity method investments	(9,558)	(1,503)
(Gain) loss on disposal of real estate and property and equipment	(989)	424
Dividends received from equity method investees	200	2,005
Deferred income	(590)	(1,429)
Derivative financial instruments	(1,249)	(1,009)
Deferred income tax	8,241	1,111
Changes in assets and liabilities:
Accounts receivable	293	(4,981)
Inventories	8,613	2,045
Other assets	1,933	1,513
Accounts payable, trade	2,589	3,030
Other liabilities	(1,529)	(4,357)
Net cash provided by operating activities	43,428	13,232
Cash flows from investing activities:
Capital expenditures	(2,159)	(2,533)
Restricted cash	(500)
Repayment of loan receivable	681
Restricted investments	280	860
Proceeds from sale of real estate and property and equipment	3,406	2,272
Net cash provided by investing activities	1,708	599
Cash flows from financing activities:
Payments of long-term debt	(18,520)	(15,179)
Stock options exercised	794	358
Noncontrolling interests distribution and other	(5)	(2,085)
Treasury stock acquired	(3,079)	(3,833)
Net cash used in financing activities	(20,810)	(20,739)
Net increase (decrease) in cash and cash equivalents	24,326	(6,908)
Cash and cash equivalents, beginning of period	69,073	75,013
Cash and cash equivalents, end of period	93,399	68,105
Non cash financing activities - Cashless exercise of stock options		1,072
Non cash investing activities – Accrued capital expenditures	$ 198	$ 93